Skip to main content

Grafa News and Videos — Page 972

Grafa Headlines

Latest

Grafa

bioAffinity Technologies reports skin cancer siRNA preclinical results

Biotechnology firm bioAffinity Technologies (NASDAQ:BIAF) announced preclinical findings showing its novel small interfering RNA therapeutic approach selectively destroys cells from two common skin cancers that affect an estimated 5.4 million annual United States cases.

Read more: bioAffinity Technologies reports skin cancer siRNA preclinical results

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift